Myasthenia gravis: Clinical case
DOI:
https://doi.org/10.35381/s.v.v6i3.2277Keywords:
Myasthenia gravis, neurophysiological, pathology. (Source, DeCS).Abstract
Objective: To analyze the clinical cases of Myasthenia gravis. Method: A bibliographic review of scientific documents such as SciELO, Scopus, PubMed and Google Scholar was carried out, which included 55 studies. Results and conclusions: Myasthenia Gravis is a disease that affects the patient and his family environment. Being an autoimmune pathology, the only solution is prior control of it, but not complete healing. It must be emphasized that these patients present many difficulties throughout their lives with MG and should always be attended by specialists in this area. The history of the disease of the patients has been obtained from their own accounts and from their relatives who, from its beginning until the day we wrote the clinical case, accompany them to face their disease.
Downloads
References
Castro-Suarez S, Caparó-Zamalloa C, Meza-Vega M. Actualización en Miastenia gravis. [Update on myasthenia gravis]. Rev Neuropsiquiatr. 2017;80(4):247. https://n9.cl/kg3iy
Zenon,T., Villalobos, J. y Rodríguez, H.(2011). Miastenia gravis: Caso clínico y revisión de bibliografía. [Myasthenia gravis: clinical case and literature review] Med Int. 27(3). 299-309. Mexico. https://n9.cl/m2yiw
Tormoehlen LM, Pascuzzi RM. Thymoma, Myasthenia Gravis, and Other Paraneoplastic Syndromes. Hematol Oncol Clin N Am 2008; 22:509-526.
Merggioli M, Sanders D. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009;8:475-490.
Deymeer F, Gungor-Tuncer O, Yilmaz V, Parman Y, Serdaroglu P et al. Clinical comparison of anti-MuSK- vs anti-acetilcolinaRpositive and seronegative myasthenia gravis. Neurology 2007; 68:609-611.
Skeie G, Apostolski S, Evoli A, Gilhus N, Hart L et al. Guidelines for the treatment of autoimmune neuromuscular trasmission disorders. European Journal of Neurology 2006;13:691-699.
Caballero Martín MA, Nieto Gómez R, Barcik U, Ntra C, Señora DR, 11 N OL. N OTA CLÍNICA . Isciii.es. https://n9.cl/b5e33
Martínez Torre S, Gómez Molinero I, Martínez Girón R. Puesta al día en la miastenia gravis.[ Update on myasthenia gravis]. Semergen. 2018;44(5):351–4. https://n9.cl/qhp1l
Tellez-Zentero, J. y Morales, L. (2000). Pathogenesis of myasthenia gravis. RIC. https://n9.cl/k865h
Castro-Suarez S, Caparó-Zamalloa C, Meza-Vega M. Actualización en Miastenia gravis. [Update on myasthenia gravis]. Rev Neuropsiquiat. 2017;80(4):247. https://n9.cl/kg3iy
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
